Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

NCT02264678 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

354

Enrollment

INDUSTRY

Sponsor class

Conditions

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer

Interventions

DRUG: Administration of ceralasertib
DRUG: Administration of ceralasertib in combination with olaparib
DRUG: Administation of ceralasertib in combination with durvalumab
DRUG: Administration of ceralasertib monotherapy
DRUG: Administration of ceralasertib and olaparib
DRUG: Administration of ceralasertib and durvalumab
DRUG: Administration of ceralasertib in combination with AZD5305
DRUG: Administration of ceralasertib in combination with carboplatin

Sponsor

AstraZeneca